ALECTOR, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.44 USD | -0.91% |
|
+3.62% | -31.83% |
| May. 14 | Transcript : Alector, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:55 AM | |
| May. 08 | Alector, Inc. Reiterates Revenue Guidance for the Year Ending 2024 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,188 | 1,199 | 1,678 | 763.3 | 671.4 | 524.3 | - | - |
| Enterprise Value (EV) 1 | 834.5 | 785.6 | 943.1 | 50.48 | 122.5 | 19.44 | -178.9 | -121.9 |
| P/E ratio | -10.1 x | -6.18 x | -45.9 x | -5.7 x | -5.12 x | -2.75 x | -3.37 x | -4.46 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 56 x | 56.8 x | 8.1 x | 5.71 x | 6.92 x | 8.25 x | 4.51 x | 2.99 x |
| EV / Revenue | 39.3 x | 37.2 x | 4.55 x | 0.38 x | 1.26 x | 0.31 x | -1.54 x | -0.69 x |
| EV / EBITDA | -7.54 x | -4.15 x | -30.4 x | -0.38 x | -0.84 x | -0.1 x | 0.91 x | 0.82 x |
| EV / FCF | -7.28 x | - | 3.19 x | -2.07 x | -0.66 x | -0.13 x | 1.4 x | 0.65 x |
| FCF Yield | -13.7% | - | 31.3% | -48.4% | -152% | -772% | 71.2% | 153% |
| Price to Book | 6.11 x | 4.49 x | 5.63 x | 3.57 x | 4.98 x | 2.94 x | 2.69 x | 2.55 x |
| Nbr of stocks (in thousands) | 68,924 | 79,243 | 81,276 | 82,702 | 84,136 | 96,385 | - | - |
| Reference price 2 | 17.23 | 15.13 | 20.65 | 9.230 | 7.980 | 5.440 | 5.440 | 5.440 |
| Announcement Date | 3/24/20 | 2/25/21 | 2/24/22 | 2/28/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 21.22 | 21.1 | 207.1 | 133.6 | 97.06 | 63.52 | 116.2 | 175.6 |
| EBITDA 1 | -110.6 | -189.3 | -31.03 | -132.1 | -146 | -203.6 | -196.6 | -149.1 |
| EBIT 1 | -114.4 | -195.2 | -37.36 | -137.8 | -151.7 | -209.9 | -179.4 | -161.2 |
| Operating Margin | -539.16% | -925.08% | -18.04% | -103.16% | -156.33% | -330.5% | -154.34% | -91.78% |
| Earnings before Tax (EBT) 1 | -105.4 | -190.2 | -36.33 | -130.1 | -125.2 | -188.1 | -146.5 | -141.1 |
| Net income 1 | -105.4 | -190.2 | -36.33 | -133.3 | -130.4 | -189 | -147.8 | -141.1 |
| Net margin | -496.65% | -901.64% | -17.54% | -99.77% | -134.34% | -297.57% | -127.19% | -80.34% |
| EPS 2 | -1.710 | -2.450 | -0.4500 | -1.620 | -1.560 | -1.977 | -1.614 | -1.220 |
| Free Cash Flow 1 | -114.6 | - | 295.3 | -24.45 | -186.5 | -150 | -127.5 | -186.6 |
| FCF margin | -539.95% | - | 142.6% | -18.3% | -192.19% | -236.12% | -109.66% | -106.3% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Announcement Date | 3/24/20 | 2/25/21 | 2/24/22 | 2/28/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 13.99 | 24.47 | 79.85 | 14.85 | 14.44 | 16.55 | 56.21 | 9.109 | 15.19 | 15.89 | 14.2 | 16.34 | 16.34 | 250 | - |
| EBITDA | - | - | - | - | - | - | - | - | -46.02 | - | - | - | - | - | - |
| EBIT 1 | -55.73 | -44.12 | 9.475 | -47.75 | -55.44 | -50.12 | -3.589 | -50.58 | -47.45 | -43.71 | -53.26 | -55.79 | -57.59 | 191.2 | -61.46 |
| Operating Margin | -398.23% | -180.29% | 11.87% | -321.49% | -383.92% | -302.83% | -6.38% | -555.31% | -312.4% | -275.01% | -375.06% | -341.39% | -352.39% | 76.46% | - |
| Earnings before Tax (EBT) 1 | -55.61 | -43.86 | 10.92 | -45.42 | -51.71 | -44.96 | 2.768 | -43.22 | -39.77 | -36.07 | -49.17 | -51.86 | -52.27 | 196.7 | -53.61 |
| Net income 1 | -55.61 | -44.62 | 9.883 | -46.15 | -52.43 | -45.86 | 1.375 | -44.48 | -41.43 | -36.08 | -49.42 | -52.11 | -52.52 | 188.5 | -53.61 |
| Net margin | -397.37% | -182.3% | 12.38% | -310.72% | -363.07% | -277.1% | 2.45% | -488.25% | -272.77% | -227.01% | -348.03% | -318.85% | -321.39% | 75.39% | - |
| EPS 2 | -0.6800 | -0.5400 | 0.1200 | -0.5600 | -0.6300 | -0.5500 | 0.0200 | -0.5300 | -0.4900 | -0.3800 | -0.5214 | -0.5371 | -0.5386 | 0.7500 | -0.4600 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/24/22 | 5/5/22 | 8/4/22 | 11/8/22 | 2/28/23 | 5/4/23 | 8/3/23 | 11/7/23 | 2/27/24 | 5/8/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 353 | 413 | 735 | 713 | 549 | 505 | 703 | 646 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -115 | - | 295 | -24.4 | -187 | -150 | -127 | -187 |
| ROE (net income / shareholders' equity) | -217% | -82.3% | -12.8% | -51.8% | -74.8% | -157% | -84.1% | -65.8% |
| ROA (Net income/ Total Assets) | - | - | - | - | -18.5% | - | - | - |
| Assets 1 | - | - | - | - | 704.7 | - | - | - |
| Book Value Per Share 2 | 2.820 | 3.370 | 3.670 | 2.590 | 1.600 | 1.850 | 2.020 | 2.130 |
| Cash Flow per Share 2 | - | -2.140 | 3.710 | -0.2500 | -2.200 | -1.590 | -1.730 | - |
| Capex 1 | 15.3 | 5.03 | 3.25 | 4.12 | 2.38 | 6.67 | 8.17 | 8.52 |
| Capex / Sales | 71.94% | 23.85% | 1.57% | 3.08% | 2.45% | 10.5% | 7.03% | 4.85% |
| Announcement Date | 3/24/20 | 2/25/21 | 2/24/22 | 2/28/23 | 2/27/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
5.44
USD
Average target price
15.44
USD
Spread / Average Target
+183.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -31.83% | 524M | |
| +9.42% | 115B | |
| +11.84% | 106B | |
| -2.65% | 21.96B | |
| -14.15% | 21.87B | |
| -5.29% | 19.21B | |
| -4.16% | 18.08B | |
| -38.29% | 17.71B | |
| +7.99% | 14.32B | |
| +36.24% | 12.42B |
- Stock Market
- Equities
- ALEC Stock
- Financials Alector, Inc.
